Symposium on clinical aspects in hepatitis virus infection. 3. Update of liver disease related to chronic hepatitis B virus infection.
Ishikawa
T
T
The First Department of Internal Medicine, Aichi Medical University, School of Medicine.
Kakumu
S
S
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D016679:Genome, Viral; D017325:Hepatitis B Vaccines; D006515:Hepatitis B virus / Q000235:genetics / Q000472:pathogenicity; D019694:Hepatitis B, Chronic / Q000188:drug therapy / Q000628:therapy* / Q000821:virology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D018664:Interleukin-12 / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D009154:Mutation
D000276:Adjuvants, Immunologic; D000305:Adrenal Cortex Hormones; D000998:Antiviral Agents; D017325:Hepatitis B Vaccines; D018664:Interleukin-12; D019259:Lamivudine; D007372:Interferons